Skip to content

Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly

Explore the Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06991855
Enrollment
90
Registered
2025-05-28
Start date
2025-07-01
Completion date
2026-04-17
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia, Sarcopenia in Elderly

Brief summary

Population aging has become a significant global concern, and Taiwan is set to officially enter the super-aged society in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process. This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatty acid supplementation on middle-aged and elderly individuals (aged 50 and above) who are at high risk for sarcopenia.

Interventions

DIETARY_SUPPLEMENTAnimal-Based Oil Group

Participants in animal-based oil group will follow a diet in which the primary fat source is animal-based oil. The diet will supplement for 12 weeks.

DIETARY_SUPPLEMENTPlant-Based Oil Group

Participants in plant-based oil group will follow a diet in which the primary fat source is plant-based oil. The diet will supplement for 12 weeks.

Sponsors

Chang Gung University
CollaboratorOTHER
Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 50 years * ASMI \< 7 kg/m2 in men * ASMI \< 5.7 kg/m2 in women * Grip strength \< 28 kg in men * Grip strength \< 18 kg in women * Walk speed \< 1 m/s

Exclusion criteria

* People who are allergic to supplements * cancer * heart failure * kidney disease * autoimmune disease * neurodegenerative disease

Design outcomes

Primary

MeasureTime frameDescription
muscle massbaseline, 12 weeksUtilize Bioelectrical Impedance Analysis (BIA) to measure the Appendicular Skeletal Muscle Mass Index Level (ASMI) (kg/m\^2)
muscle functionbaseline, 12 weeksutilize handgrip dynamometer to measure the hand grip strength (kg).
physical functionbaseline, 12 weeksTo assess the participant's walking speed over a 4-meter distance.

Countries

Taiwan

Contacts

Primary ContactHsiang-Yu Tang, Ph.D.
tangshyu@cgu.edu.tw+886-3-2118800
Backup ContactYi Tsang Chen, Master of Science
ytchen@fpg.com.tw+886-2-2712-2211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026